Hwei-Fang Tien

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Venues

National Taiwan University Hospital

National Taiwan University College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Taiwan University Hospital

Taiwan

Chief :: Hematology-Oncology Section, Department of Internal Medicine

National Taiwan University College of Medicine

Taiwan

Professor :: Department of Internal Medicine

National Taiwan University Hospital

Taiwan

Visiting Staff :: Division of Hematology and Oncology, Department of Internal Medicine

Education History

National Taiwan University College of Medicine

Taiwan

PHD :: Graduate Institute of Clinical Medicine

Publications

Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood cancer journal 14 (1) (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood cancer journal 14 (1) (2024)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia. Blood cancer journal 14 (1) (2024)
Chieh-Lung Cheng, You-Yu Lin, Chia-Lang Hsu, Chiao-Ling Li, Chang-Tsu Yuan, Ya-Yun Lai, Wei-Quan Fang, Pei-Jer Chen, Shiou-Hwei Yeh, Hwei-Fang Tien
Unraveling the role of hepatitis B virus DNA integration in B-cell lymphomagenesis. British journal of cancer (2024)
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Shan-Chi Yu, Ming-Chih Liu, Chang-Tsu Yuan, Yi-Tsung Yang, Ming-Kai Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Hwei-Fang Tien, Hsin-An Hou, Wen-Chien Chou
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms. Blood cancer journal 14 (1) (2024)
Yi-Tsung Yang, Chi-Yuan Yao, Chein-Jun Kao, Po-Ju Chiu, Ming-En Lin, Hsin-An Hou, Chien-Chin Lin, Wen-Chien Chou, Hwei-Fang Tien
Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy. British journal of haematology (2024)
Chien-Chin Lin, Chi-Yuan Yao, Yuan-Yeh Kuo, Yueh-Chwen Hsu, Chang-Tsu Yuan, Tsung-Chih Chen, Chia-Lang Hsu, Sze-Hwei Lee, Jhih-Yi Lee, Pin-Tsen Shih, Chein-Jun Kao, Po-Han Chuang, Yuan-Yeh Kuo, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo. EJHaem 5 (4) (2024)
Chien-Chin Lin, Chi-Yuan Yao, Yuan-Yeh Kuo, Yueh-Chwen Hsu, Chang-Tsu Yuan, Tsung-Chih Chen, Chia-Lang Hsu, Sze-Hwei Lee, Jhih-Yi Lee, Pin-Tsen Shih, Chein-Jun Kao, Po-Han Chuang, Yuan-Yeh Kuo, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo. EJHaem 5 (4) (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia. Blood cancer journal 14 (1) (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao, Andres Jerez, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien, Kiran Batta, Daniel H Wiseman
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia. Blood cancer journal 14 (1) (2024)
Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood cancer journal 13 (1) (2023)
Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood cancer journal 13 (1) (2023)
Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood cancer journal 13 (1) (2023)
Wan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Yi-Tsung Yang, Jui-Che Chen, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Liang-In Lin, Wen-Chien Chou, Chien-Chin Lin, Hsin-An Hou, Hwei-Fang Tien
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification. Blood cancer journal 13 (1) (2023)
Xavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, Feng-Ming Tien, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Yen-Ling Peng, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Hsun-I Sun, Ming-Chih Liu, Chia-Wen Liu, Chien-Chin Lin, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. Blood cancer journal 13 (1) (2023)
Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Bettina Wingelhofer, Fabio M R Amaral, Chi-Yuan Yao, Hsin Ting Hsieh, Ming Chih Liu, Hsin-An Hou, Wen-Chien Chou, Kiran Batta, Daniel H Wiseman, Hwei-Fang Tien
Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target. Leukemia (2023)
Yu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, Chi-Ling Chen, Chia-Lang Hsu, Xavier Cheng-Hong Tsai, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Higher RUNX1 expression levels are associated with worse overall and leukaemia-free survival in myelodysplastic syndrome patients. EJHaem 3 (4) (2022)
Tsung-Chih Chen, Chi-Yuan Yao, Yu-Ren Chen, Chang-Tsu Yuan, Chien-Chin Lin, Yueh-Chwen Hsu, Po-Han Chuang, Chein-Jun Kao, Yi-Hung Li, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair. Oncogene 41 (11) (2022)
Kuan-Wei Su, Da-Liang Ou, Yu-Hsuan Fu, Hwei-Fang Tien, Hsin-An Hou, Liang-In Lin
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias. Cancer gene therapy (2021)
Yu-Hung Wang, Chien-Chin Lin, Chi-Yuan Yao, Chia-Lang Hsu, Xavier Cheng-Hong Tsai, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome. British journal of haematology (2021)
Yu-Hung Wang, Hsin-An Hou, Chien-Chin Lin, Yuan-Yeh Kuo, Chi-Yuan Yao, Chia-Lang Hsu, Mei-Hsuan Tseng, Xavier Cheng-Hong Tsai, Yen-Ling Peng, Chein-Jun Kao, Wen-Chien Chou, Hwei-Fang Tien
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes. Blood advances 5 (22) (2021)
Feng-Ming Tien, Xavier Cheng-Hong Tsai, Sheng-Chuan Huang, Jia-Hau Liu, Chien-Yuan Chen, Yuan-Yeh Kuo, Yi-Kuang Chuang, Mei-Hsuan Tseng, Yen-Ling Peng, Ming-Chih Liu, Chia-Wen Liu, Xiu-Wen Liao, Liang-In Lin, Yu-Sin Wu, Mei-Fang Hou, Shang-Ju Wu, Szu-Chun Hsu, Bor-Sheng Ko, Wen-Chien Chou, Ming Yao, Hsin-An Hou, Jih-Luh Tang, Hwei-Fang Tien
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission. Bone marrow transplantation (2021)
Xavier Cheng-Hong Tsai, Jih-Luh Tang, Feng-Ming Tien, Yuan-Yeh Kuo, Dung-Chi Wu, Chien-Chin Lin, Mei-Hsuan Tseng, Yen-Ling Peng, Mei-Fang Hou, Yi-Kuang Chuang, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, Wen-Chien Chou, Chien-Yu Chen, Hsin-An Hou, Hwei-Fang Tien
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML. Blood advances 5 (10) (2021)
Chien-Chin Lin, Chi-Yuan Yao, Yueh-Chwen Hsu, Hsin-An Hou, Chang-Tsu Yuan, Yi-Hung Li, Chein-Jun Kao, Po-Han Chuang, Yu-Chiao Chiu, Yidong Chen, Wen-Chien Chou, Hwei-Fang Tien
Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice. Oncogene 39 (28) (2020)
Yu-Hung Wang, Chien-Chin Lin, Sze-Hwei Lee, Xavier Cheng-Hong Tsai, Shan-Ju Wu, Hsin-An Hou, Tai-Chung Huang, Yuan-Yeh Kuo, Ming Yao, Koping Chang, Chung-Wu Lin, Yun-Chu Lin, Feng-Ming Tien, Wen-Chien Chou, Jih-Luh Tang, Hwei-Fang Tien
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden. Blood cancer journal 10 (10) (2020)

Hwei-Fang Tien.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hwei-Fang Tien